Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer

NCT02076594 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

171

Enrollment

OTHER

Sponsor class

Stopped The interim analysis performed on 09 November 2018, showed the failure to achieve the primary objective of effectiveness of the experimental treatment.

Conditions

Locally Advanced Unresectable Gastric Cancer
Metastatic Gastric Cancer

Interventions

DRUG: Docetaxel
DRUG: Epirubicin
DRUG: Oxaliplatin
DRUG: Capecitabine

Sponsor

Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente

Collaborators

[object Object]